Clinical Trial

Sleep More, Stress Less: 90-Day Trial of Neuralli Mood

Study acronym: NM90
Recruiting
View on ClinicalTrials.gov →
Summary
This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.
Trial Details
NCT Number NCT07717385
Lead Sponsor Efforia, Inc
Collaborators: Bened Life
Conditions Psychological Stress, Sleep Disturbance, Anxiety Symptoms, Depressive Symptoms, Occupational Burnout
Enrollment 100 participants
Start Date 2026-06-30
Primary Completion 2027-09-28 (estimated)
Study Completion 2027-09-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-21